소아용 정맥주사 부목 시장 예측(2026-2032년)

The Pediatric I.V. Arm Boards Market is projected to grow by USD 1.82 billion at a CAGR of 6.65% by 2032.

Pediatric I.V. Arm Boards: Executive Summary

Pediatric I.V. arm boards are supportive medical devices used to stabilize a child's limb during intravenous access and infusion. Their design must balance immobilization, comfort, visibility of the insertion site, skin protection, infection-control requirements, and compatibility with pediatric clinical workflows. Demand is shaped by hospital safety priorities, procedural volume, neonatal and pediatric care capacity, and the need for reliable devices across emergency, inpatient, outpatient, and transport settings.

Clinical Design Is Shifting Toward Safer, More Adaptable Support

The product landscape is moving from basic rigid supports toward designs that emphasize atraumatic stabilization, adjustable fit, lightweight construction, breathable materials, and rapid application. Pediatric variation in age, body size, skin sensitivity, and mobility increases the importance of scalable sizing and secure fastening without excessive pressure. Reusable products face stronger cleaning and material-durability expectations, while single-use options support infection-control protocols and operational convenience. Hospitals are also placing greater emphasis on ergonomic handling, clear inspection of the cannula site, and integration with broader pediatric vascular-access policies.

Artificial Intelligence Improves Selection, Monitoring, and Workflow Coordination

Artificial intelligence can contribute indirectly to this market by supporting clinical documentation, identifying patients at higher risk of line dislodgement or infiltration, and analyzing workflow data to improve device selection and replacement practices. Computer-vision tools may assist with observing limb position, dressing integrity, or visible complications when appropriate safeguards are in place. These applications remain dependent on validated data, human oversight, privacy controls, and integration with electronic health records. AI is therefore most useful as a decision-support and operational tool rather than as a substitute for pediatric clinical judgment or direct site assessment.

Regional Insights: Regulation, Pediatric Capacity, and Supply Practices Differ

North America generally emphasizes standardized hospital protocols, product safety documentation, and workflow efficiency across pediatric and neonatal services. Europe places strong weight on medical-device compliance, infection prevention, sustainability, and consistent procurement standards, while the European Union provides an important regulatory context. Asia-Pacific combines advanced pediatric care capabilities in selected markets with significant variation in hospital infrastructure, purchasing processes, and access to specialized devices. Latin America is influenced by public-sector procurement, local distribution capacity, and differences in pediatric hospital resources. The Middle East shows demand linked to expanding tertiary-care and specialized hospital systems, with procurement often tied to institutional standards and import requirements. Africa presents diverse conditions, including constrained supply chains in some settings and growing emphasis on durable, affordable, and easy-to-use clinical equipment.

Group Insights: Healthcare Alliances and Economic Blocs Shape Access

ASEAN markets reflect varied regulatory systems and healthcare-development levels, making distributor capability, product documentation, and adaptable procurement strategies important. BRICS countries combine large and diverse healthcare systems with different domestic manufacturing, registration, and public-purchasing environments. The European Union encourages attention to harmonized compliance, traceability, and environmental considerations. G7 systems typically maintain advanced clinical governance and strong expectations for evidence, quality assurance, and user safety. GCC countries often prioritize high-acuity hospital development, centralized purchasing, and dependable imported medical-device supply. NATO members do not share a single healthcare procurement system, but many operate within mature regulatory and emergency-preparedness frameworks that can elevate the importance of resilient supply and standardized clinical procedures.

Country Insights: Local Care Models and Procurement Rules Matter

Australia's geographically dispersed healthcare network increases the value of dependable distribution and products suited to varied hospital settings. Brazil and Mexico must account for regional differences in pediatric capacity, public procurement, and regulatory administration. Canada and the United States place substantial emphasis on hospital protocols, safety documentation, and clinical usability. China and India combine extensive pediatric needs with diverse hospital tiers and evolving domestic manufacturing and registration environments. Japan and South Korea tend to emphasize quality, precision, and established hospital purchasing practices. France, Germany, Italy, and Spain operate within the European regulatory environment while retaining distinct procurement and care-delivery structures. The United Kingdom emphasizes clinical governance, infection prevention, and evidence-informed purchasing across its healthcare system. Russia's market conditions are influenced by domestic supply considerations, regulatory requirements, and uneven access across regions.

Action Priorities for Leaders in Pediatric Vascular-Access Support

Industry leaders should prioritize adjustable, low-trauma designs that preserve visibility of the insertion site and accommodate meaningful differences in pediatric anatomy. Product development should include documented usability testing with clinicians, caregivers, and age-appropriate patient groups, alongside validation of fastening, pressure distribution, cleaning, and material safety. Portfolio planning should distinguish requirements for neonatal, infant, child, and adolescent use rather than relying on a single universal configuration. Commercial teams should strengthen regulatory files, local registration capabilities, distributor training, and after-sales support. Hospitals should establish selection criteria covering comfort, securement, inspection access, infection control, disposal or reprocessing, and staff training. Digital tools, including AI-enabled monitoring, should be introduced only through controlled evaluation, transparent governance, and clear accountability for clinical decisions.

Research Methodology: Structured Review of Clinical, Regulatory, and Operational Evidence

This executive summary uses a structured market-analysis framework focused on the clinical role and purchasing context of pediatric I.V. arm boards. The assessment considers product design characteristics, pediatric vascular-access practices, infection-control expectations, hospital workflow requirements, regulatory considerations, and regional differences in healthcare delivery. Regional, group, and country observations are synthesized from established healthcare and medical-device context rather than speculative commercial modeling. No market estimates, market shares, forecasts, or company-specific claims are included. Findings should be validated against current national regulations, institutional protocols, procurement criteria, and product-specific technical documentation before operational decisions are made.

Conclusion: Safety, Fit, and Workflow Integration Define Competitive Relevance

Pediatric I.V. arm boards occupy a focused but clinically important role in protecting vascular access and supporting safe infusion care. The strongest value proposition centers on dependable stabilization, pediatric-appropriate comfort, rapid visual assessment, infection-control compatibility, and ease of use across care environments. Regional and country differences make regulatory readiness, local supply resilience, and adaptable product configurations essential. Leaders that combine human-centered design with disciplined clinical validation and carefully governed digital support will be better positioned to address evolving pediatric care requirements.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Pediatric I.V. Arm Boards Market, by Product Type

• 7.1. Introduction
• 7.2. Soft Padding
  • 7.2.1. Gel Foam
  • 7.2.2. Memory Foam
• 7.3. Standard Hard Board

8. Pediatric I.V. Arm Boards Market, by Material

• 8.1. Introduction
• 8.2. Fabric
  • 8.2.1. Cotton
  • 8.2.2. Polyester
• 8.3. Foam
  • 8.3.1. Memory Foam
  • 8.3.2. Polyurethane Foam
• 8.4. Gel
  • 8.4.1. Silicone Gel
  • 8.4.2. Water Gel

9. Pediatric I.V. Arm Boards Market, by End User

• 9.1. Introduction
• 9.2. Ambulatory Centers
  • 9.2.1. Clinics
  • 9.2.2. Surgical Centers
• 9.3. Home Care
• 9.4. Hospitals
  • 9.4.1. General Ward
  • 9.4.2. Neonatal Intensive Care Unit
  • 9.4.3. Pediatric Intensive Care Unit

10. Pediatric I.V. Arm Boards Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Direct Sales
• 10.3. Medical Supply Distributors
• 10.4. Online Retail

11. Pediatric I.V. Arm Boards Market, by Region

• 11.1. Introduction
• 11.2. Asia-Pacific
• 11.3. North America
• 11.4. Latin America
• 11.5. Europe
• 11.6. Middle East
• 11.7. Africa

12. Pediatric I.V. Arm Boards Market, by Group

• 12.1. Introduction
• 12.2. ASEAN
• 12.3. GCC
• 12.4. European Union
• 12.5. BRICS
• 12.6. G7
• 12.7. NATO

13. Pediatric I.V. Arm Boards Market, by Country

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. United Kingdom
• 13.7. Germany
• 13.8. France
• 13.9. Russia
• 13.10. Italy
• 13.11. Spain
• 13.12. China
• 13.13. India
• 13.14. Japan
• 13.15. Australia
• 13.16. South Korea

14. Competitive Landscape

• 14.1. Market Share Analysis, 2025
• 14.2. Market Concentration Analysis, 2025
  • 14.2.1. Concentration Ratio (CR)
  • 14.2.2. Herfindahl Hirschman Index (HHI)
• 14.3. Recent Developments & Impact Analysis, 2025
• 14.4. Product Portfolio Analysis, 2025
• 14.5. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. 3M Company
• 15.2. Armstrong Medical Industries Inc
• 15.3. Becton Dickinson and Company
• 15.4. Boen Medical Co Ltd
• 15.5. Cardinal Health Inc
• 15.6. Cook Medical LLC
• 15.7. Dale Medical Products Inc
• 15.8. DeRoyal Industries Inc
• 15.9. DiaMedical USA Inc
• 15.10. DICK Medical Supply Company
• 15.11. Fulflex Healthcare Solutions Inc
• 15.12. Grayline Medical LLC
• 15.13. Honest Medical LLC
• 15.14. Life-Assist LLC
• 15.15. McKesson Corporation
• 15.16. Medline Industries Inc
• 15.17. MFI Medical Inc
• 15.18. PDC Healthcare Inc
• 15.19. Precision Dynamics Corporation
• 15.20. Protection Products Inc
• 15.21. Redax SA
• 15.22. Shenzhen Bestman Precision Instrument Co Ltd
• 15.23. Smiths Group plc
• 15.24. Veol Medical Technologies Pvt Ltd
• 15.25. Weigao Group Co Ltd

16. Key Experts